Oral anticoagulation after intracranial haemorrhage: A survey of UK stroke physicians
Oral anticoagulation after intracranial haemorrhage: A survey of UK stroke physicians
Introduction: Observational studies suggest that starting oral anticoagulation (OAC) after intracranial haemorrhage (ICH) is beneficial, but a randomised controlled trial (RCT) is needed to confirm this. We assessed opinion about this treatment uncertainty amongst stroke physicians in the UK. Method: In May 2015, we used Survey Monkey to email an online questionnaire to 289 doctors on the delegation logs at 111 hospital sites participating in the REstart or STop Antithrombotics Randomised Trial (www.RESTARTtrial.org; ISRCTN71907627), followed by 3 email reminders to non-responders. Results: Of 289 invitees, one had opted out of Survey Monkey, 17 emails bounced, 109 (38%) did not respond, and 15 partially completed the survey, leaving 147 (51%) complete responses. 95% of respondents were uncertain whether to start OAC in at least some patients with indications for OAC after ICH. Physicians would randomise patients with atrial fibrillation (AF) and a CHA2DS2-VASc score >1 (88%), recurrent venous thromboembolism (78%) or other cardiac indications (80%). One quarter of respondents would prefer to use adjusted dose warfarin and the rest would use a new OAC (of whom 50% would use apixaban and 29% would use any new OAC). In a RCT the preferred comparator was avoidance of all antithrombotic drugs for patients with lone AF (73%) and an antiplatelet drug for patients with a past history of vaso-occlusive disease (89%). 82% of respondents were just as, or more, keen to participate in RESTART-OAC than RESTART-antiplatelets. Discussion: Equipoise about starting OAC after ICH and physicians' keenness to participate support the need for RESTART-OAC.
Journal: Conference Abstract *cerebrovascular acci
28-29
Marigold, Richard
23c9f4cc-a1da-41a0-84bd-8e1aee91ed78
British Association of Stroke Physicians
2015
Marigold, Richard
23c9f4cc-a1da-41a0-84bd-8e1aee91ed78
Marigold, Richard
,
British Association of Stroke Physicians
(2015)
Oral anticoagulation after intracranial haemorrhage: A survey of UK stroke physicians.
International Journal of Stroke, 10, .
Abstract
Introduction: Observational studies suggest that starting oral anticoagulation (OAC) after intracranial haemorrhage (ICH) is beneficial, but a randomised controlled trial (RCT) is needed to confirm this. We assessed opinion about this treatment uncertainty amongst stroke physicians in the UK. Method: In May 2015, we used Survey Monkey to email an online questionnaire to 289 doctors on the delegation logs at 111 hospital sites participating in the REstart or STop Antithrombotics Randomised Trial (www.RESTARTtrial.org; ISRCTN71907627), followed by 3 email reminders to non-responders. Results: Of 289 invitees, one had opted out of Survey Monkey, 17 emails bounced, 109 (38%) did not respond, and 15 partially completed the survey, leaving 147 (51%) complete responses. 95% of respondents were uncertain whether to start OAC in at least some patients with indications for OAC after ICH. Physicians would randomise patients with atrial fibrillation (AF) and a CHA2DS2-VASc score >1 (88%), recurrent venous thromboembolism (78%) or other cardiac indications (80%). One quarter of respondents would prefer to use adjusted dose warfarin and the rest would use a new OAC (of whom 50% would use apixaban and 29% would use any new OAC). In a RCT the preferred comparator was avoidance of all antithrombotic drugs for patients with lone AF (73%) and an antiplatelet drug for patients with a past history of vaso-occlusive disease (89%). 82% of respondents were just as, or more, keen to participate in RESTART-OAC than RESTART-antiplatelets. Discussion: Equipoise about starting OAC after ICH and physicians' keenness to participate support the need for RESTART-OAC.
This record has no associated files available for download.
More information
Published date: 2015
Keywords:
Journal: Conference Abstract *cerebrovascular acci
Identifiers
Local EPrints ID: 506229
URI: http://eprints.soton.ac.uk/id/eprint/506229
ISSN: 1747-4930
PURE UUID: e95b7882-59a5-4ee5-a033-aa66f0aae792
Catalogue record
Date deposited: 30 Oct 2025 17:46
Last modified: 30 Oct 2025 17:46
Export record
Contributors
Author:
Richard Marigold
Corporate Author: British Association of Stroke Physicians
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics